Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 1 Mar 2024
- Ended
- 1 Feb 2025
- Type of study
- Observational, 2 groups
- Treatments tested
- serum zinc and magnesium
- Record updated
- 14 February 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Chronic liver disease diagnosed by physical examination, laboratory investigations, and imaging study
Who cannot take part
- Drugs affecting levels of trace elements e.g. corticosteroids, digoxin thiazide, diuretics, and supplements 30 days before study
- Patients with Wilson disease
- Patients with chronic renal diseases
- Patients with IBD or any other cause of chronic diarrhea
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational cross-sectional study is to assess the relationship between serum levels of magnesium and zinc in pediatric and adult patients with chronic liver disease and the clinic-laboratory variables.
Read full original descriptionShow less
Researchers will compare serum levels of zinc and magnesium in patients with chronic liver disease and healthy controls. Assess the correlation between serum zinc and magnesium and the presence and severity of chronic liver disease and cirrhosis.
Participants will be subjected to history taking, clinical examination, laboratory investigations, and abdominal ultrasonography.
The 2 groups in the trial
- Control
60 healthy subjects as control.
Treatment: serum zinc and magnesium
- Chronic liver disease
80 patients with chronic liver disease diagnosed by physical examination, laboratory investigations, and imaging study. This group will be subdivided into non-cirrhotic and cirrhotic liver groups.
Treatment: serum zinc and magnesium
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Study of Serum Zinc and Magnesium as Trace Elements in Patients With Chronic Liver Disease
- Record updated
- 14 February 2025